BRPI0906045A2 - "composição farmacêutica para administração nasal" - Google Patents

"composição farmacêutica para administração nasal"

Info

Publication number: BRPI0906045A2
Authority: BR; Brazil
Prior art keywords: pharmaceutical composition; nasal administration; nasal; administration; pharmaceutical
Prior art date: 2008-02-28

Application number

BRPI0906045-6A

Other languages

English (en)

Inventor

Mariko Morishita

Kozo Takayama

Nobuo Ida

Reiji Nishio

Original Assignee

Toray Industries

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-02-28

Filing date

2009-02-27

Publication date

2015-07-07

2009-02-27 Application filed by Toray Industries filed Critical Toray Industries

2015-07-07 Publication of BRPI0906045A2 publication Critical patent/BRPI0906045A2/pt

2022-01-25 Publication of BRPI0906045B1 publication Critical patent/BRPI0906045B1/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
- C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Insects & Arthropods (AREA)
Organic Chemistry (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Toxicology (AREA)
Diabetes (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Endocrinology (AREA)
Otolaryngology (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

BRPI0906045-6A 2008-02-28 2009-02-27 Composição farmacêutica para administração nasal BRPI0906045B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2008-048300		2008-02-28
JP2008048300		2008-02-28
PCT/JP2009/053648 WO2009107766A1 (ja)	2008-02-28	2009-02-27	経鼻投与用医薬組成物

Publications (2)

Publication Number	Publication Date
BRPI0906045A2 true BRPI0906045A2 (pt)	2015-07-07
BRPI0906045B1 BRPI0906045B1 (pt)	2022-01-25

Family

ID=41016151

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0906045-6A BRPI0906045B1 (pt)	2008-02-28	2009-02-27	Composição farmacêutica para administração nasal

Country Status (13)

Country	Link
US (1)	US8895503B2 (pt)
EP (1)	EP2253326B1 (pt)
JP (2)	JP4711013B2 (pt)
KR (1)	KR101585046B1 (pt)
CN (1)	CN101959532B (pt)
AU (1)	AU2009218060B2 (pt)
BR (1)	BRPI0906045B1 (pt)
CA (1)	CA2716565C (pt)
ES (1)	ES2671024T3 (pt)
MX (1)	MX2010009148A (pt)
PL (1)	PL2253326T3 (pt)
RU (1)	RU2470666C2 (pt)
WO (1)	WO2009107766A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL2433953T3 (pl) *	2009-05-20	2015-12-31	Toray Industries	Peptydy o zdolności przenikania przez błonę komórkową
JP2014502953A (ja) *	2010-08-16	2014-02-06	ザトラスティースオブコロンビアユニバーシティインザシティオブニューヨーク	細胞透過性治療薬の鼻腔内送達
CN112313749B (zh) *	2018-04-13	2025-02-07	香港理工大学	使用肽的数据存储
CN112367974A (zh) *	2018-05-15	2021-02-12	DNALite治疗学公司	粘液穿透肽、递送媒介和治疗方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4153689A (en) *	1975-06-13	1979-05-08	Takeda Chemical Industries, Ltd.	Stable insulin preparation for nasal administration
JPS6068176A (ja) *	1983-09-26	1985-04-18	Kobe Steel Ltd	厚板Ｃｒ―Ｍｏ―Ｖ系耐熱鋼の突合わせ溶接方法
US4789660A (en) *	1987-09-10	1988-12-06	American Home Products Corporation	Insulin administration using methyl and propyl paraben
JPH0242027A (ja)	1988-08-02	1990-02-13	Minofuaagen Seiyaku Honpo:Goushi	経粘膜吸収促進剤及びこれを用いた経鼻投与剤
CA2135642C (en)	1992-08-21	1999-12-14	James G. Barsoum	Tat-derived transport polypeptides
ATE285212T1 (de) *	1993-10-07	2005-01-15	Odontex Inc	Absorptionsförderer für topische pharmazeutische formulierungen
KR19990063632A (ko) *	1995-09-21	1999-07-26	디 헤이쓰, 산드라 우드	약물 운송용 트란스사이토시스 매개체 및 상승제
JP3770666B2 (ja)	1996-09-20	2006-04-26	株式会社ティ・ティ・エス技術研究所	経粘膜吸収製剤用組成物
GB9814527D0 (en)	1998-07-03	1998-09-02	Cyclacel Ltd	Delivery system
ATE331532T1 (de) *	1998-08-26	2006-07-15	Teijin Ltd	Pulverförmige pernasale mittel
ATE419273T1 (de)	1998-11-13	2009-01-15	Cyclacel Ltd	Translokationsvektoren abgeleitet von der antennapedia homeodomain helix 3
US6960431B2 (en) *	2001-08-22	2005-11-01	Myriad Genetics, Inc.	Therapeutic compositions and methods for treating viral infection
US20040254146A1 (en) *	2002-05-21	2004-12-16	Nastech Pharmaceutical Company Inc.	Carboxylate salts of galantamine and their pharmaceutical use
KR20050049525A (ko)	2002-10-11	2005-05-25	가부시키가이샤산와카가쿠켄큐쇼	Ｇｌｐ-1 유도체 및 그의 경점막 흡수형 제제
US7166575B2 (en) *	2002-12-17	2007-01-23	Nastech Pharmaceutical Company Inc.	Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
US20040147027A1 (en) *	2003-01-28	2004-07-29	Troy Carol M.	Complex for facilitating delivery of dsRNA into a cell and uses thereof
US7329638B2 (en) *	2003-04-30	2008-02-12	The Regents Of The University Of Michigan	Drug delivery compositions
CN101018560A (zh) *	2004-09-15	2007-08-15	大塚制药株式会社	经粘膜用组合物及提高经粘膜吸收的方法
US7442682B2 (en)	2004-10-19	2008-10-28	Nitto Denko Corporation	Transepithelial delivery of peptides with incretin hormone activities
JP5103748B2 (ja) *	2005-02-16	2012-12-19	東レ株式会社	医薬組成物
KR100729830B1 (ko) *	2005-03-24	2007-06-19	바이오스펙트럼 주식회사	페너트라틴을 이용하여 단백질의 세포투과를 증진시키는대장균용발현벡터
WO2006112738A1 (en) *	2005-04-19	2006-10-26	Auckland Uniservices Limited	Novel peptides and methods for the treatment of inflammatory disorders
NZ566281A (en) *	2005-07-27	2010-08-27	Mdrna Inc	Tight junction modulating peptide comprising the amino acid seqeunce CNGRCGGKKKLKLLLKLL and combinations thereof with therapeutic agents
KR20080084937A (ko) *	2005-11-04	2008-09-22	포휴먼텍(주)	융합 폴리펩타이드를 세포로 전달하는 방법
CA2646833C (en) *	2005-12-30	2019-07-30	Evonik Roehm Gmbh	Peptides useful as cell-penetrating peptides
CA2654207A1 (en) *	2006-06-08	2007-12-21	Cpex Pharmaceuticals, Inc.	Insulin composition
JP5076374B2 (ja) *	2006-06-28	2012-11-21	東レ株式会社	医薬組成物
US20080076701A1 (en) *	2006-08-18	2008-03-27	Nastech Pharmaceutical Company Inc.	Dicer substrate rna peptide conjugates and methods for rna therapeutics

2009
- 2009-02-27 AU AU2009218060A patent/AU2009218060B2/en not_active Ceased
- 2009-02-27 EP EP09715976.8A patent/EP2253326B1/en not_active Not-in-force
- 2009-02-27 CA CA2716565A patent/CA2716565C/en active Active
- 2009-02-27 US US12/867,701 patent/US8895503B2/en active Active
- 2009-02-27 PL PL09715976T patent/PL2253326T3/pl unknown
- 2009-02-27 MX MX2010009148A patent/MX2010009148A/es active IP Right Grant
- 2009-02-27 RU RU2010139769/15A patent/RU2470666C2/ru active
- 2009-02-27 KR KR1020107019311A patent/KR101585046B1/ko not_active Expired - Fee Related
- 2009-02-27 WO PCT/JP2009/053648 patent/WO2009107766A1/ja not_active Ceased
- 2009-02-27 ES ES09715976.8T patent/ES2671024T3/es active Active
- 2009-02-27 CN CN2009801068174A patent/CN101959532B/zh not_active Expired - Fee Related
- 2009-02-27 JP JP2009510212A patent/JP4711013B2/ja not_active Expired - Fee Related
- 2009-02-27 BR BRPI0906045-6A patent/BRPI0906045B1/pt not_active IP Right Cessation
2011
- 2011-01-27 JP JP2011015623A patent/JP5212492B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP2253326A4 (en)	2013-01-09
BRPI0906045B1 (pt)	2022-01-25
WO2009107766A1 (ja)	2009-09-03
MX2010009148A (es)	2010-12-06
ES2671024T3 (es)	2018-06-04
EP2253326A1 (en)	2010-11-24
JPWO2009107766A1 (ja)	2011-07-07
CN101959532B (zh)	2013-02-27
JP5212492B2 (ja)	2013-06-19
JP4711013B2 (ja)	2011-06-29
US8895503B2 (en)	2014-11-25
RU2470666C2 (ru)	2012-12-27
KR101585046B1 (ko)	2016-01-13
EP2253326B1 (en)	2018-04-04
AU2009218060B2 (en)	2014-08-28
KR20100135730A (ko)	2010-12-27
CA2716565A1 (en)	2009-09-03
US20110020280A1 (en)	2011-01-27
CN101959532A (zh)	2011-01-26
AU2009218060A1 (en)	2009-09-03
RU2010139769A (ru)	2012-04-10
JP2011084581A (ja)	2011-04-28
CA2716565C (en)	2017-09-12
PL2253326T3 (pl)	2018-09-28

Publication	Publication Date	Title
BRPI0808293A2 (pt)	2019-09-24	"composições para administração nasal"
LTPA2018014I1 (lt)	2018-12-10	Farmacinė kompozicija 514
BRPI0810928A2 (pt)	2019-09-24	"composição farmacêutica"
LTPA2018005I1 (lt)	2018-02-12	Farmacinė kompozicija
EP3777939C0 (en)	2023-06-07	NASAL ROYALTY
EP2381773A4 (en)	2012-12-12	COMPOSITIONS FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS
BRPI0913379A2 (pt)	2015-11-24	formulações farmacêuticas sólidas compreendendo bibw 2992
BRPI0916877A2 (pt)	2016-02-10	composição farmacêutica e administração da mesma
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
BRPI0820381A2 (pt)	2015-05-19	Formulações farmacêuticas
BRPI1008598A2 (pt)	2016-03-15	composição farmacêutica para inalação
EP2152195A4 (en)	2012-10-31	PEPTIDATE MEDICINAL FOR ORAL LEVY
DK3492069T3 (da)	2022-03-14	Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
EP2219725A4 (en)	2011-05-18	CUFFS FOR ACTIVE INJECTION
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
BRPI0809661A2 (pt)	2014-10-14	Composição farmacêutica estabilizada contendo pregabalina
EP2643009A4 (en)	2015-04-01	COMPOSITION FOR THE RELEASE OF BIODEGRADABLE ACTIVE SUBSTANCES
BRPI1007484A2 (pt)	2016-02-16	composição farmacêutica para administração oral
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica
EP2062579A4 (en)	2010-03-03	SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING OPTICALLY STABLE RAMOSETRON
BRPI0918539A2 (pt)	2015-12-08	preparação farmacêutica sólida para administração oral
EP2193795A4 (en)	2013-09-18	AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING LATANOPROST
BRPI1005932A2 (pt)	2017-05-02	composto, composição farmacêutica para inalação e inalador
DK2271321T3 (da)	2012-08-27	Farmaceutisk sammensætning 271
EP2156832A4 (en)	2010-11-24	PHARMACEUTICAL COMPOSITION

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-07-31	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2019-07-16	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2020-11-10	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2021-12-07	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2022-01-25	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/02/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.
2023-12-19	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 15A ANUIDADE.
2024-04-09	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2763 DE 19-12-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.